Pathologic Diagnosis of Well-differentiated Hepatocellular Lesions: A Practical Approach to Diagnosis With Particular Focus in Core Needle Biopsies and Utilization of Ancillary Techniques
- PMID: 37264525
- DOI: 10.1097/PAP.0000000000000402
Pathologic Diagnosis of Well-differentiated Hepatocellular Lesions: A Practical Approach to Diagnosis With Particular Focus in Core Needle Biopsies and Utilization of Ancillary Techniques
Abstract
Common well-differentiated hepatocellular lesions include focal nodular hyperplasia, focal nodular hyperplasia-like lesions, large regenerative nodule, hepatocellular adenoma, dysplastic nodule, and hepatocellular carcinoma. The term atypical hepatocellular neoplasm/hepatocellular neoplasm of uncertain malignant potential can be used especially in needle core biopsies when a well-differentiated hepatocellular lesion is either histologically atypical (focal reticulin loss, focal cytologic/architectural atypia) or is clinically atypical (male sex or female >50 y) and cannot be confidently classified as adenoma or hepatocellular carcinoma. These are resected in an attempt for more definite classification. Although radiology can suggest the diagnosis in some of the entities mentioned above, needle core biopsies are often performed to confirm the diagnosis and plan therapy. Diagnosis of these lesions on needle core biopsies can be challenging and may have overlapping histologic and sometimes even immunohistochemical features. Herein, we review the histologic, immunohistochemical, and molecular features of well-differentiated hepatocellular lesions, along with recent advances in this area. We also provide the best approach for the diagnosis of well-differentiated hepatocellular lesions with ancillary testing, especially on needle core biopsies, and discuss the pitfalls. Accurate recognition of well-differentiated hepatocellular lesions is essential as some of them have excellent prognosis and may not require resection, while others have histologic prognostic information that is key for management.
Keywords: atypical hepatocellular neoplasm; focal nodular hyperplasia; glutamine synthetase; hepatic adenoma; hepatocellular neoplasm of uncertain potential; immunohistochemistry; well-differentiated hepatocellular carcinoma.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Similar articles
-
A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.Arch Pathol Lab Med. 2015 Apr;139(4):537-42. doi: 10.5858/arpa.2013-0645-OA. Arch Pathol Lab Med. 2015. PMID: 25822763
-
Differential diagnosis of hepatocellular nodular lesions.Semin Diagn Pathol. 1998 Nov;15(4):285-99. Semin Diagn Pathol. 1998. PMID: 9845429 Review.
-
Evaluating Liver Biopsies with Well-Differentiated Hepatocellular Lesions.Surg Pathol Clin. 2023 Sep;16(3):581-598. doi: 10.1016/j.path.2023.04.011. Epub 2023 Jun 9. Surg Pathol Clin. 2023. PMID: 37536890 Review.
-
Role of genomic analysis in the classification of well differentiated hepatocellular lesions.Hum Pathol. 2025 Apr;158:105794. doi: 10.1016/j.humpath.2025.105794. Epub 2025 May 13. Hum Pathol. 2025. PMID: 40374146
-
Fine needle aspiration biopsy of hepatocellular carcinoma and hepatocellular nodular lesions: role, controversies and approach to diagnosis.Cytopathology. 2011 Oct;22(5):287-305. doi: 10.1111/j.1365-2303.2011.00882.x. Epub 2011 Jul 18. Cytopathology. 2011. PMID: 21762411 Review.
Cited by
-
Androgen-Induced, β-Catenin-Activated Hepatocellular Adenomatosis with Spontaneous External Rupture.Diagnostics (Basel). 2024 Jul 9;14(14):1473. doi: 10.3390/diagnostics14141473. Diagnostics (Basel). 2024. PMID: 39061609 Free PMC article.
-
The evolving role of liver biopsy: Current applications and future prospects.Hepatol Commun. 2025 Jan 7;9(1):e0628. doi: 10.1097/HC9.0000000000000628. eCollection 2025 Jan 1. Hepatol Commun. 2025. PMID: 39774070 Free PMC article. Review.
References
-
- Mathieu D, Kobeiter H, Maison P, et al. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology. 2000; 118:560–564.
-
- Kim TK, Jang HJ, Burns PN, et al. Focal nodular hyperplasia and hepatic adenoma: differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol. 2008;190:58–66.
-
- Roux M, Pigneur F, Baranes L, et al. Correction to: differentiating focal nodular hyperplasia from hepatocellular adenoma: is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? Abdom Radiol (NY). 2018;43:2212.
-
- Rowan DJ, Allende DS, Bellizzi AM, et al. Diagnostic challenges of focal nodular hyperplasia: interobserver variability, accuracy, and the utility of glutamine synthetase immunohistochemistry. Histopathology. 2021;79:791–800.
-
- Bioulac-Sage P, Cubel G, Taouji S, et al. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes. AmJSurgPathol. 2012;36:1691–1699.
LinkOut - more resources
Full Text Sources